MIT engineers create nanoparticles for delivering personalized cancer vaccines
October 30, 2026
The particles carry a customized dose of cancer antigens that can provoke a strong immune response against tumors.
The particles carry a customized dose of cancer antigens that can provoke a strong immune response against tumors.
Data supporting the expanded clearance came from the HALT study involving 130 patients.
Fox Chase Cancer Center researchers identified a potential therapeutic target for pancreatic cancer after showing that tumor growth can be slowed and immune suppression can be reduced in preclinical trials by blocking a particular protein, called anoctamin 6 (ANO6).
A patient has undergone pioneering stem-cell therapy to treat Parkinson’s disease, the Japanese drugmaker behind the treatment said on Friday, in a world first following its conditional approval in the country.
The immune system may recognize a cancer cell and still fail to destroy it. In a recent study, researchers at Hiroshima University and their international collaborators found that hyperactive YAP and TAZ (YAP/TAZ), two cancer-promoting proteins, were associated with genomic instability that may make cancer cells more recognizable to the immune system, while also increasing PD-L2, which helps the cells suppress T-cell attack.
A simple vaginal swab may one day help women with abnormal bleeding learn whether they have endometrial cancer without first going through a painful biopsy.
MIT researchers have shown that they can accurately track muscle movement using tiny magnetic beads implanted in the muscle. These measurements could make it easier for people with certain types of amputations to control their prosthetic limbs.
FDA authorization enables clinical investigation of a fundamentally different approach for patients with early symptomatic Alzheimer’s disease
A single dose of an antibody targeting immune cells helped some monkeys stay free of detectable virus long after stopping treatment.
Northwestern Medicine scientists and collaborators have demonstrated a novel liquid biopsy technique that can measure cancer burden and reveal molecular characteristics of small cell lung cancer (SCLC), according to a new study published in the Journal of Clinical Investigation.